Author:
Huang Yu,Guo Dong-Ming,Bu Shi,Xu Wei,Cai Qing-Chun,Xu Jian,Jiang Yue-Quan,Teng Fei
Funder
Performance incentives guide special key project of Chongqing scientific research institutes
Laboratory opening fund of Chongqing University Cancer Hospital
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference61 articles.
1. Araujo LH, Timmers C, Bell EH, et al. Genomic characterization of non-small-cell lung cancer in African Americans by targeted massively parallel sequencing. J Clin Oncol. 2015;33(17):1966–73.
2. Wang W, Zhao M, Cui L, et al. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer. Mol Cancer. 2020;19(1):134.
3. Kim JW, Marquez CP, Kostyrko K, et al. Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Nat Med. 2019;25(11):1783–95.
4. Wu S, Shen G, Mao J, Gao B. CT radiomics in predicting EGFR mutation in non-small cell lung cancer: a single institutional study. Front Oncol. 2020;10: 542957.
5. Liu H, Li D, Fang H, Ning J. Species-specific function of microRNA-7702 in human colorectal cancer cells via targeting TADA1. Am J Transl Res. 2018;10(8):2579–89.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献